SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SABRATEK CORP (SBTK) -- Ignore unavailable to you. Want to Upgrade?


To: Kevin Podsiadlik who wrote (294)7/6/1999 11:43:00 AM
From: mod  Respond to of 487
 
Volume is looking better (200k), and the pop is even nicer, up $2 3/4 or 12%. I liked the news this morning, so I added some more SBTK at $23 1/4.

At the current price of over $24, almost all of the outstanding July puts will expire worthless. Besides the increasing SBTK price, the decreasing volatility is acting as a double whammy on anybody who had the misfortune to buy puts. No way any put holders are in the money anymore. And anyone who did the "patented reverse combo" of buying puts and shorting calls, is getting killed big time.



To: Kevin Podsiadlik who wrote (294)7/6/1999 11:58:00 AM
From: mod  Read Replies (1) | Respond to of 487
 
Kevin,

Getting a little damp yet? I suggest you cover before you start floating out of here. Being short a stock on the verge of becoming an internet health play is not smart. Given that the "trading halt" never showed up, and is less likely to with each day that goes by, there is much more risk to being short right now then can possibly be justified by the bogus Pluvia/Milberg allegations.

Cut your losses now and bail (and I mean this in a friendly way).

mod